🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Non-Communicable Chronic Diseases

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases NCT06581770n/a1 site📍 Istanbul Istanbul Galata University · Tests: Survey using a questionnaire., Survey using a questionnaire. Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） NCT06323681NA1 site📍 Shanghai Qing XIe · Tests: Peginterferon α-2b based treatment group, NAs monotherapy group Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: Nucleos(t)ide Analogs (NA) TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load. NCT05195450NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: Tenofovir alafenamide fumarate Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB) NCT05578495NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: Accelerometer data BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS NCT07118683n/a9 sites📍 Goiânia📍 Belo Horizonte📍 Curitiba Hospital Alemão Oswaldo Cruz Evaluation of the WARIFA App and Its Impact on Healthy Lifestyle NCT06918444NA1 site📍 Las Palmas de Gran Canaria Instituto Universitario de Investigaciones Biomédicas y San… · Tests: WARIFA app with AI, WARIFA app without AI Community-Based Chronic Disease Care in Rural Lesotho NCT05596773n/a2 sites📍 Maseru📍 Basel University Hospital, Basel, Switzerland Feasibility Study of a Digital Interactive Life-style Platform for Individuals After Rehabilitation NCT07597031NA2 sites📍 Bern📍 Schwendi Matthias Wilhelm, MD · Tests: Digital Lifestyle Platform, Usual Care (Standard Post-Rehabilitation Care) Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077Phase 41 site📍 Baltimore Mercy Medical Center · Tests: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD NCT05766449n/a1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites📍 Klagenfurt📍 Vienna📍 Aachen CytoSorbents, Inc · Tests: CytoSorb Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data NCT07743021n/a33 sites📍 Balatonfüred📍 Békéscsaba📍 Budapest Center for Molecular Fingerprinting Research Nonprofit LLC Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT） NCT06368882Phase 45 sites📍 Ningbo📍 Rui’an📍 Wenzhou First Affiliated Hospital of Wenzhou Medical University · Tests: Peg-Interferon α Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease NCT02863757n/a1 site📍 Hong Kong Humanity and Health Research Centre Long-term Evaluation of Gestational Endocrine & Metabolic Dynamics NCT07119177n/a1 site📍 Beijing Yang ZHANG Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites📍 Budapest📍 Budapest📍 Budapest Semmelweis University Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations NCT07604610n/a1 site📍 Moscow National Medical Research Center for Therapy and Preventive… Cohort in Qianwan New District, Ningbo NCT06387875n/a1 site📍 Shanghai RenJi Hospital Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia NCT07442318NA4 sites📍 Addis Ababa📍 Harar📍 Adama Norwegian Institute of Public Health · Tests: Structured lifestyle counseling integrated into ANC, Standard routine ANC Effectiveness of Physical Exercise of Patients With Chronic Non-communicable Disease NCT06476015n/a1 site📍 Medellín Fundacion Universitaria Maria Cano · Tests: Therapeutic exercise "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". NCT04690972n/a1 site📍 Strasbourg Institut National de la Santé Et de la Recherche Médicale, … · Tests: Blood sample during surgery, Taking an additional biopsy, Blood sample during diagnostic test Effects of a Pulmonary and Cardiovascular Rehabilitation Program NCT06772922NA1 site📍 Campinas University of Campinas, Brazil · Tests: Exercise Health Warnings and Counseling for Smoking Cessation NCT07098065NA1 site📍 Dhaka Hitotsubashi University · Tests: Graphical health warnings, Graphical health warnings plus pharmacist-led counselling, Routine pharmacy services (no int… Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction NCT06953180n/a1 site📍 Almaty Asfendiyarov Kazakh National Medical University · Tests: Genetic: DNA analysis The Bern Rehab Registry NCT06516172n/a2 sites📍 Heiligenschwendi📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Comprehensive disease-specific rehabilitation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy